Overview

A Study of the Effects of Increasing Doses of a Drug for the Treatment of Nail Fungus

Status:
Completed
Trial end date:
2009-12-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine an upper dose of albaconzole to be administered in a Thorough QTc study.
Phase:
Phase 1
Details
Lead Sponsor:
Stiefel, a GSK Company
Collaborator:
GlaxoSmithKline